Literature DB >> 17051735

Protective effect of endothelin antagonist (TAK-044) on neuronal cell viability in in vitro oxygen-glucose deprivation model of stroke.

Seema Briyal1, Aditya B Pant, Y K Gupta.   

Abstract

The present study was carried to investigate the effect of endothelin antagonist (TAK-044) in an in vitro model of stroke using primary neuronal culture. Hypoxia in neuronal culture was induced for 3 h using oxygen glucose deprivation (OGD) model, thereafter cells were reperfused. In separate group cultures were incubated with graded concentrations of TAK-044 (0.01, 0.1 and 1 microg/microl) for different time duration i.e. 6, 12 and 24 hours after reperfusion. Percent cell viability was assessed 24 h after reperfusion using MTT assay. It was observed that percent cell viability was reduced to 13.7 +/- 0.4% in the cells under 3 h hypoxic condition as compared to the cells under normal condition (100%). TAK-044 at the concentrations of 0.1 and 1 microg/microl, but not at 0.01 microg/microl showed significant (P<0.01) improvement in the % cell viability as compared to the cells in hypoxic condition. Percent cell viability at the concentration of 0.1 and 1 microg/microl for 24 h time duration after reperfusion were 54.8 +/- 3.2% and 75.4 +/- 1.8% respectively as compared to the cells under hypoxic condition (13.7 +/- 0.4%). The results demonstrate the neuroprotective effect of TAK-044 against neuronal damage caused by hypoxia induced in neuronal culture.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17051735

Source DB:  PubMed          Journal:  Indian J Physiol Pharmacol        ISSN: 0019-5499


  3 in total

Review 1.  Potential of immunosuppressive agents in cerebral ischaemia.

Authors:  Yogendra Kumar Gupta; Anjali Chauhan
Journal:  Indian J Med Res       Date:  2011-01       Impact factor: 2.375

2.  Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke.

Authors:  Anil Gulati; Nilesh Agrawal; Deepti Vibha; U K Misra; Birinder Paul; Dinesh Jain; Jeyaraj Pandian; Rupam Borgohain
Journal:  CNS Drugs       Date:  2021-01-11       Impact factor: 5.749

Review 3.  Sovateltide Mediated Endothelin B Receptors Agonism and Curbing Neurological Disorders.

Authors:  Amaresh K Ranjan; Anil Gulati
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.